Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: A randomized, placebo controlled trial

Affiliations

Mark O Turner: Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Patrick R Johnston: Asthma Research Group, Department of Medicine, St Joseph’s Hospital and McMaster University, Hamilton, Ontario, Canada
Emilio Pizzichini: Respiratory Division, Department of Internal Medicine, University of Santa Catarina (UFSC), Florianópolis, Brazil
Marcia MM Pizzichini: Respiratory Division, Department of Internal Medicine, University of Santa Catarina (UFSC), Florianópolis, Brazil
Pat A Hussack: Asthma Research Group, Department of Medicine, St Joseph’s Hospital and McMaster University, Hamilton, Ontario, Canada
Frederick E Hargreave: Asthma Research Group, Department of Medicine, St Joseph’s Hospital and McMaster University, Hamilton, Ontario, Canada

Abstract

BACKGROUND: Salmeterol is a potent long acting beta-agonist that is effective in relieving the symptoms and airflow limitation of asthma.

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503